Drug Search by Year (Detail)

25061542

CA

Aphonia, Nasopharyngitis, Pneumonia, Productive cough, Road traffic accident, Sinusitis, Tendonitis, Tissue injury, Arthralgia, Weight decreased, Wheezing, Body temperature decreased, Drug hypersensitivity, Ear infection, Hypoventilation, Limb discomfort, Middle ear effusion, Cough, Rash, Product use issue, Off label use,

AMOXICILLIN, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE,

25061584

CA

Anaphylactic shock, Anxiety, Arthralgia, Arthritis, Asthenia, Asthma, Blood pressure systolic increased, Bronchitis, Burnout syndrome, COVID-19, Chest discomfort, Cough, Diarrhoea, Drug hypersensitivity, Drug ineffective, Dust allergy, Dysphonia, Dyspnoea, Eczema, Fatigue, Forced expiratory volume decreased, Hypoaesthesia, Hypoventilation, Incorrect dose administered, Influenza, Localised infection, Lower respiratory tract infection, Malaise, Middle insomnia, Motor dysfunction, Nasal congestion, Nasopharyngitis, Nausea, Obstructive airways disorder, Oral infection, Oropharyngeal pain, Pain, Pharyngeal swelling, Pyrexia, Rhinorrhoea, Sneezing, Tympanic membrane perforation, Vertebral foraminal stenosis, Vomiting, Weight decreased, Weight increased, Wheezing,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACLIDINIUM BROMIDE, BUDESONIDE, PREDNISONE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, ALBUTEROL SULFATE,

25061780

US

Dysphonia, Speech disorder, Nasopharyngitis,

FREMANEZUMAB-VFRM,

25061892

CA

Breast cancer, Bronchitis, Fatigue, Influenza, Nasopharyngitis, Pneumonia, Respiratory tract infection,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE,

25061908

CA

Chills, Colitis ulcerative, Diarrhoea, Mobility decreased, Nasal congestion, Oropharyngeal pain, Vision blurred, Malaise, Asthenia, Haematochezia, Intestinal haemorrhage, Rectal haemorrhage, SARS-CoV-2 test positive, Fatigue, Injection site bruising, Injection site erythema, Injection site pain, Injection site reaction, Nasopharyngitis, Pyrexia, Device difficult to use, Drug ineffective, Incorrect dose administered, Off label use, Intentional product use issue,

ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, IRON SUCROSE,

25062007

GB

Peroneal nerve palsy, Hypoaesthesia, Fall, COVID-19, Nasopharyngitis, Bone pain, Sleep disorder, Pain in extremity, Arthralgia,

SECUKINUMAB,

25062098

CA

Asthma, Breast cancer, Breath sounds abnormal, Bronchial obstruction, COVID-19, Chest pain, Cough, Dyspnoea, Fall, Gastrooesophageal reflux disease, General physical health deterioration, Nasal congestion, Nasopharyngitis, Obesity, Open fracture, Productive cough, Sputum discoloured, Upper respiratory tract infection, Weight decreased, Wheezing, Wrist fracture, Wrong technique in product usage process, Off label use,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE,

25062139

CA

Asthma, Blood pressure systolic increased, Body temperature decreased, Contusion, Cough, Dyspnoea, Dyspnoea exertional, Fatigue, Forced expiratory volume decreased, Injection site bruising, Injection site swelling, Malaise, Middle insomnia, Nasopharyngitis, Obstructive airways disorder, Product dose omission issue, Pulmonary function test decreased, Weight decreased, Weight increased, Wheezing,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ACLIDINIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, AMLODIPINE, AMLODIPINE BESYLATE, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL,

25062421

CZ

Illness, Respiratory tract infection, Gastrointestinal disorder, COVID-19, Nasopharyngitis,

ADALIMUMAB,

25062442

US

Nasopharyngitis,

LENALIDOMIDE,

25062457

CA

Pneumonia, Nasopharyngitis,

VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,

25062486

CA

Appetite disorder, Arthralgia, Asthenia, Asthma, Blood pressure systolic increased, Body temperature decreased, Breath sounds abnormal, Carpal tunnel syndrome, Chest pain, Cholelithiasis, Cough, Discomfort, Dizziness, Dysphonia, Dyspnoea, Forced expiratory volume decreased, Headache, Hypoaesthesia, Illness, Jaw disorder, Lower respiratory tract infection, Malaise, Nasopharyngitis, Obstructive airways disorder, Poor quality sleep, Procedural pain, Rales, SARS-CoV-2 test positive, Sinusitis, Skin reaction, Stress, Wheezing, Weight decreased,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, GLYCOPYRROLATE, MONTELUKAST SODIUM,

25062569

US

Nasopharyngitis, Cough, Chest pain,

LENALIDOMIDE,

25062583

US

Nephrolithiasis, Renal procedural complication, Kidney infection, Critical illness, Kidney infection, Loss of consciousness, Multiple fractures, Immunodeficiency, Hip fracture, Somnolence, Urinary tract infection pseudomonal, Urosepsis, Pneumonia, Accident at work, Allergy to chemicals, Nasopharyngitis, Eye infection, Insomnia, Occupational asthma, Reactive airways dysfunction syndrome, Product dose omission issue, Wrong technique in device usage process, Device malfunction,

BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, IPRATROPIUM BROMIDE,

25062633

US

Nasopharyngitis,

ADALIMUMAB,

25062743

US

Abdominal pain upper, Nasopharyngitis, Constipation, Diarrhoea,

ABEMACICLIB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, OMEPRAZOLE MAGNESIUM,

25062745

US

Nasopharyngitis, Tremor,

TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE,

25062826

CA

Abdominal pain upper, Asthma, Cough, Drug ineffective, Dyspnoea, Illness, Malaise, Nasopharyngitis, Oropharyngeal pain, Product distribution issue, Tachypnoea, Weight decreased,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE FUROATE, FLUTICASONE FUROATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL,

25062866

US

Nasopharyngitis,

ABATACEPT,

25062887

CA

Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation,

ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, APREMILAST, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, APREMILAST, CANDESARTAN CILEXETIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB,

25062906

US

Nasopharyngitis,

PALBOCICLIB, OIL, BIOTIN, HAIR,

25063108

US

Muscle spasms, Fatigue, Nasopharyngitis, Chest discomfort,

VISMODEGIB,

25063127

CA

Asthma, Bronchospasm, Dyspnoea, Hypersensitivity, Nasal congestion, Nasal polyps, Nasopharyngitis, Pyrexia, Wheezing,

OMALIZUMAB, CICLESONIDE, CITALOPRAM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE, MONTELUKAST, PANTOPRAZOLE, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE,

25063137

US

Nasopharyngitis, Diarrhoea,

LENALIDOMIDE,

25063199

CA

Chronic rhinosinusitis with nasal polyps, Coeliac disease, Dermatitis contact, Drug hypersensitivity, Drug ineffective, Fatigue, Inappropriate schedule of product administration, Incorrect dose administered, Musculoskeletal stiffness, Nasopharyngitis, Skin irritation, Urticaria chronic,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PENICILLIN G BENZATHINE,

25063208

US

Ear infection, Nasopharyngitis, Intentional dose omission,

TROFINETIDE,

25063329

CA

Asthma, Contusion, Cystitis, Fall, Fatigue, Feeling hot, Heart rate increased, Hypersensitivity, Lower respiratory tract infection, Nasopharyngitis, Off label use, Peripheral swelling, Radial pulse increased, Skeletal injury, Skin laceration, Swelling face, Urticaria, Weight decreased, Weight increased,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, RAMIPRIL, RAMIPRIL,

25063375

CA

Blood pressure increased, Bronchitis, Eye injury, Hypoacusis, Illness, Ligament sprain, Nasopharyngitis, Oedema, Productive cough, Respiratory rate increased, Seasonal allergy, Sputum discoloured, Influenza like illness, Wrong technique in product usage process, Inappropriate schedule of product administration,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE FUROATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION, CITALOPRAM, CITALOPRAM HYDROBROMIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE,

25063403

CA

Asthenia, Dizziness, Nasopharyngitis, Urticaria, Vitamin B12 deficiency, Off label use,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE,

25063472

CA

Asthma, Blindness, Blood pressure systolic increased, Body temperature decreased, Drug intolerance, Dysphonia, Dyspnoea, Eczema eyelids, Eye pruritus, Foreign body sensation in eyes, Gait disturbance, Heart rate increased, Injection site discomfort, Injection site pain, Macular degeneration, Mass, Nasopharyngitis, Pain in extremity, Product storage error, Rash, Retinal detachment, Stress, Urticaria, Wheezing, Wound,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE,

25063533

US

Death, Nasopharyngitis,

MIFEPRISTONE, ALBUTEROL SULFATE, ALBUTEROL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, HYDROCHLOROTHIAZIDE, LOSARTAN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE,

25063550

US

Nasopharyngitis,

PIMAVANSERIN TARTRATE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARBIDOPA AND LEVODOPA, FINASTERIDE, LISINOPRIL, POLYETHYLENE GLYCOL 3350, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, CARBIDOPA AND LEVODOPA, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE,

25063636

CA

Bronchitis, COVID-19, Chest discomfort, Cough, Ear pruritus, Fall, Forced expiratory volume decreased, Gastroenteritis viral, Head injury, Hypersensitivity, Illness, Lacrimation increased, Lower respiratory tract infection, Nasopharyngitis, Peripheral swelling, Pulmonary oedema, Pyrexia, Respiratory rate increased, Rhinorrhoea, Secretion discharge, Seizure, Sinus congestion, Sinusitis, Sleep disorder, Swelling, Throat irritation, Urticaria, Weight decreased,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, ALBUTEROL SULFATE,

25063752

CA

Asthma, Back pain, Blood pressure systolic increased, Body temperature increased, Breath sounds abnormal, Chest discomfort, Cough, Dyspnoea, Gait disturbance, Heart rate increased, Inappropriate schedule of product administration, Influenza, Injection site haemorrhage, Malaise, Middle insomnia, Nasopharyngitis, Nephrolithiasis, Oropharyngeal pain, Pain in extremity, Pneumonia, Product dose omission issue, Pyrexia, Respiratory rate increased, Sneezing, Vomiting, Weight decreased, Wheezing,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY,

25064081

CA

Immunosuppression, Bronchopulmonary aspergillosis, Infection susceptibility increased, Nasopharyngitis, Sinusitis,

OMALIZUMAB, OMALIZUMAB,

25064164

CA

Asthma, Blood pressure decreased, Cough, Dyspnoea, Eye pruritus, Forced expiratory volume decreased, Forced vital capacity decreased, Inappropriate schedule of product administration, Lacrimation increased, Nasopharyngitis, Obstructive airways disorder, Pulmonary fibrosis, Respiratory rate decreased, Rhinitis allergic, Sensitivity to weather change, Therapy non-responder, Weight decreased, Weight increased, Wheezing,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ALBUTEROL SULFATE, ALBUTEROL SULFATE,

25064256

US

Nasopharyngitis,

C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, FLUOXETINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, FEXOFENADINE HYDROCHLORIDE, MONTELUKAST SODIUM, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, PRAZOSIN HYDROCHLORIDE, CLONAZEPAM, DIPHENHYDRAMINE HYDROCHLORIDE, OMALIZUMAB, BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES,

25064304

CA

Angioedema, Blood oestrogen decreased, Ear swelling, Erythema, Illness, Inappropriate schedule of product administration, Lichen planus, Lip swelling, Nasopharyngitis, Peripheral swelling, Product availability issue, Pruritus, Rash, Skin abrasion, Urticaria, Weight decreased, Weight increased,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, MEDROXYPROGESTERONE ACETATE, PREDNISONE, PREDNISONE,

25064476

CA

Asthma, Cough, Dust allergy, Frustration tolerance decreased, Gastrointestinal disorder, Illness, Insomnia, Lymphadenitis, Middle insomnia, Nasal congestion, Nasopharyngitis, Oropharyngeal pain, Pyrexia, Respiratory tract infection, Sialoadenitis, Sinusitis, Viral infection, Vomiting,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMOXICILLIN, FLUTICASONE FUROATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, ALBUTEROL SULFATE,

25064534

CA

Bone erosion, Breast cancer stage II, Bursitis, C-reactive protein, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Confusional state, Contusion, Crohn^s disease, Adjustment disorder with depressed mood, Deep vein thrombosis postoperative, Disability, Dry mouth, Dyspepsia, Dyspnoea, Exostosis, Facet joint syndrome, Feeling hot, Fluid retention, Frequent bowel movements, Anti-cyclic citrullinated peptide antibody, Folliculitis, Gait disturbance, Gait inability, Gastrointestinal disorder, General symptom, Grip strength decreased, Hepatic cirrhosis, Hypercholesterolaemia, Ill-defined disorder, Impaired healing, Amnesia, Incorrect route of product administration, Infection, Inflammation, Insomnia, Irritable bowel syndrome, Joint stiffness, Laryngitis, Lip dry, Liver disorder, Lower limb fracture, Anxiety, Lower respiratory tract infection, Lung disorder, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Migraine, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Arthritis, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Night sweats, Pain in extremity, Paraesthesia, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Asthma, Prescribed underdose, Pruritus, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash vesicular, Red blood cell sedimentation rate increased, Vaginal discharge, Sleep disorder, Autoimmune disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Therapy non-responder, Thrombocytopenia, Underdose, Urticaria, Weight decreased, Weight increased, Wound infection, Back disorder, X-ray abnormal,

TRAMADOL HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, METHYLPREDNISOLONE, MESALAMINE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, NAPROXEN, NAPROXEN SODIUM, NEOMYCIN OINTMENT, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PHENYLEPHRINE HYDROCHLORIDE, RAMIPRIL, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, METHYLPREDNISOLONE SODIUM SUCCINATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CALCIUM CARBONATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOFACITINIB,

25064614

US

Death, Respiratory failure, Pulmonary function test decreased, Respiratory disorder, Condition aggravated, Nasopharyngitis, Liver disorder, Lymphadenopathy, Weight decreased,

RIBOCICLIB,

25064620

CA

Arthralgia, Blood pressure increased, Breast pain, Bronchitis, Cough, Drug hypersensitivity, Dyspnoea, Eczema, Erythema, Fall, Fluid retention, Hypersensitivity, Menstrual disorder, Nasopharyngitis, Oropharyngeal pain, Rash, Rotator cuff syndrome, Shoulder fracture, Skin discolouration, Sputum discoloured, Thermal burn, Type 2 diabetes mellitus, Urinary tract infection, Urticaria, Weight decreased, Weight increased, Product availability issue, Product dose omission issue,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, CEFPROZIL, LORATADINE, LORATADINE TABLET, MONTELUKAST, ALBUTEROL SULFATE,

25064661

CA

Asthma, Bronchial obstruction, Chronic obstructive pulmonary disease, Cough, Hypoxia, Lung hyperinflation, Middle insomnia, Nasal congestion, Nasopharyngitis, Obstructive airways disorder, Rhinorrhoea,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, HYDROCHLOROTHIAZIDE, LISINOPRIL, PANTOPRAZOLE, ALBUTEROL SULFATE, ALBUTEROL SULFATE,

25064682

US

Surgery, Cyst, Nasopharyngitis, Malaise,

RISANKIZUMAB-RZAA,

25064803

CA

COVID-19, Decreased immune responsiveness, Diverticulitis, Dyspepsia, Erythema, Eye pruritus, Eye swelling, Fatigue, Feeling abnormal, Hypersensitivity, Infected cyst, Intervertebral disc protrusion, Weight decreased, Pain, Pneumonia, Pruritus, Rash, Rhinorrhoea, Skin plaque, Sneezing, Urticaria chronic, Swelling, Nasopharyngitis, Oropharyngeal pain, Urticaria, Product storage error, Product dose omission issue, Inappropriate schedule of product administration,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY,

25065030

US

Nasopharyngitis, Macular degeneration, Ligament sprain,

INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A,

25065187

CA

Bronchiolitis, Vaginal infection, Dry skin, Headache, Dizziness, Flushing, Grip strength decreased, Muscular weakness, Neck pain, Pain, Hypoaesthesia, Sinusitis, Oropharyngeal pain, Back pain, Drug ineffective, Insomnia, Vision blurred, Rash pruritic, Nasopharyngitis, Fatigue, Cough, Wheezing, Dyspnoea, Illness, Malaise, Product dose omission issue, Inappropriate schedule of product administration,

METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE,

25065500

US

Raynaud^s phenomenon, Nasopharyngitis, Fatigue,

RELUGOLIX, RELUGOLIX, BICALUTAMIDE, AMLODIPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL,

25065630

US

Constipation, Diarrhoea, Decreased appetite, Nasopharyngitis, Malaise, Feeling abnormal, Nausea, Vomiting,

REVUMENIB, REVUMENIB, EXEMESTANE, CYCLOSPORINE, ZOLEDRONIC ACID, ALBUTEROL SULFATE, ALBUTEROL, BENZONATATE, MOMETASONE FUROATE, MOMETASONE,

25065653

US

Hysterectomy, Nasopharyngitis, Rheumatoid arthritis,

UPADACITINIB, UPADACITINIB,

25065654

US

Cardiac disorder, Oxygen consumption increased, Migraine, Dizziness, Nausea, Vomiting, Heart rate increased, Malaise, Nasopharyngitis, COVID-19, Balance disorder, Fall, Infusion site swelling, Oxygen saturation decreased, Seasonal allergy, Illness, Diarrhoea, Headache, Infusion site pain, Dyspnoea, Application site pruritus, Application site pain, Infusion site infection, Hypotension, Device malfunction,

TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ALBUTEROL SULFATE, AMBRISENTAN, DIPHENHYDRAMINE HYDROCHLORIDE, FUROSEMIDE, NORTRIPTYLINE HYDROCHLORIDE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TREPROSTINIL, TADALAFIL, TREPROSTINIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN,

25065717

US

Vitreous floaters, Nasopharyngitis, Middle ear effusion, Respiratory tract congestion,

ADALIMUMAB,

25065880

GB

Cholecystectomy, Nasopharyngitis, Hyperchlorhydria, Nephropathy toxic,

RISANKIZUMAB-RZAA, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM,

25065926

CA

Haematochezia, Sinus congestion, Nasopharyngitis,

INFLIXIMAB,

25067684

Nasopharyngitis,

ADALIMUMAB,

25067688

Nasopharyngitis,

ADALIMUMAB,

25056420

CA

Platelet count decreased, Respiratory tract infection, Depressed mood, Contusion, Haematocrit decreased, Mean cell volume increased, Platelet count decreased, Serum ferritin increased, Red blood cell count decreased, Haemoglobin decreased, White blood cell count decreased, Neutrophil count decreased, Fatigue, Illness, Dizziness, Nausea, Nasopharyngitis,

ELTROMBOPAG, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, PREDNISONE, PANTOPRAZOLE, ACYCLOVIR, CYANOCOBALAMIN, BISOPROLOL FUMARATE, AMLODIPINE, SILDENAFIL CITRATE, HEPARIN SODIUM, APIXABAN,

25056424

US

Nasopharyngitis,

OCRELIZUMAB,

25056431

US

Hospitalisation, Rheumatoid arthritis, Claustrophobia, COVID-19, Nasopharyngitis, Vertigo, Nightmare, Treatment noncompliance, Off label use,

CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CLONAZEPAM, CLONAZEPAM, PREGABALIN, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOHPEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN 325MG/ DEXTROMETHORPHAN HBR 10MG/ PHENYLEPHRINE HCL 5MG, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HCL, ACETAMINOPHEN, DEXTROMETHORPHAN HBR,GUAIFENESIN, PHENYLEPHRINE HCL, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCI 325, 10, 5 MG SOFTGELS, DEXTROMETHORPHAN HYDROBROMIDE, ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN DEXTROMETHORPHAN HBR PHENYLEPHRINE HCL, ACETAMINOPHINE DEXTROMETHORPHAN HBR PHENYLPHRINE HCL, CARIPRAZINE, VIBEGRON, SEMAGLUTIDE,

25056819

US

Device difficult to use, Drug dose omission by device, Nasopharyngitis,

EVOLOCUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DUPILUMAB, GUAIFENESIN,

25056862

GB

Thrombosis, Nasopharyngitis,

ETANERCEPT,

25057161

US

Memory impairment, Nasopharyngitis,

PIMAVANSERIN TARTRATE,

25057170

CA

Anxiety, COVID-19, Decreased immune responsiveness, Exposure to SARS-CoV-2, Inappropriate schedule of product administration, Nasopharyngitis, Off label use, Rash, Urticaria, Weight decreased, Weight increased,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CYCLOSPORINE, CYCLOSPORINE, LORATADINE, LORATADINE ORAL, LIRAGLUTIDE, PREDNISONE,

25057587

US

Nasopharyngitis, Illness, Drug dose omission by device, Device breakage,

ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, METHYLPREDNISOLONE,

25058038

US

Ear congestion, Dyspnoea, Nasopharyngitis,

TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE,

25058163

US

Nasopharyngitis, Incorrect dose administered,

TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE,

25058352

US

Nasopharyngitis, Respiratory tract infection viral,

TOFACITINIB, SPIRONOLACTONE,

25058384

US

Nasopharyngitis, Product dispensing error,

BOSUTINIB,

25058387

US

Nasopharyngitis,

TOFACITINIB,

25058432

CA

Pneumonia, Off label use, Nasopharyngitis,

VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE,

25059507

CA

Heart rate increased, Illness, Nasopharyngitis, Influenza, Pain, Hypersomnia, Product dose omission issue,

GOLIMUMAB,

25060069

US

Nasopharyngitis, Sinusitis,

INSULIN GLARGINE,

25060100

US

Nasopharyngitis, Influenza, Lethargy, Pain,

DUPILUMAB, ALLOPURINOL, BENAZEPRIL HYDROCHLORIDE, COLCHICINE, FERROUS SULFATE, GLIMEPIRIDE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SEMAGLUTIDE, TAMSULOSIN HYDROCHLORIDE, INSULIN DEGLUDEC, ACETAMINOPHEN, VITAMIN E, CREAM,

25060122

US

Illness, Nasopharyngitis, Urticaria,

DUPILUMAB, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ALLOPURINOL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS,

25060200

CA

Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Contraindicated product administered, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Musculoskeletal pain, Wound infection, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain,

TRAMADOL HYDROCHLORIDE, PANTOPRAZOLE, PREDNISONE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, INFLIXIMAB, RISEDRONATE SODIUM, ERENUMAB-AOOE, RITUXIMAB, FISH OIL, GOLIMUMAB, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, DICLOFENAC SODIUM, TOFACITINIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM,

25060220

US

Nasopharyngitis,

DUPILUMAB, MAVACAMTEN,

25060297

US

Influenza, Nasopharyngitis,

DUPILUMAB, DUPILUMAB,

25060374

US

Nasopharyngitis, Anosmia,

DUPILUMAB, DUPILUMAB,

25060555

CA

Hospitalisation, Cognitive disorder, Nasopharyngitis, Upper respiratory tract infection, Malaise, Impetigo, Rash, Tooth abscess, Off label use, Inappropriate schedule of product administration, Product dose omission issue,

ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ,

25060559

US

Blood sodium decreased, Cough, Nasopharyngitis,

BRODALUMAB,

25060563

CA

Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Musculoskeletal pain, Liver function test increased, Lung disorder, Memory impairment, Mobility decreased, Muscle injury, Muscle spasms, Nail disorder, Nasopharyngitis, Nausea, Obesity, Off label use, Contraindicated product administered, Glossodynia,

ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ETANERCEPT, CANDESARTAN, CANDESARTAN, LEFLUNOMIDE, OXYCODONE, PANTOPRAZOLE, LEFLUNOMIDE, LEFLUNOMIDE, BUPRENORPHINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, ABATACEPT, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CYCLOBENZAPRINE, AZELAIC ACID, CELECOXIB, CELECOXIB, ALENDRONATE SODIUM, INFLIXIMAB, INFLIXIMAB, LEVOMILNACIPRAN, PHOSPHORUS, MINOCYCLINE, NAPROXEN, NAPROXEN SODIUM,

25060581

US

Product communication issue, Device difficult to use, Drug dose omission by device, Nasopharyngitis, Cough,

EVOLOCUMAB, TIRZEPATIDE,

25060636

US

Nasopharyngitis, Fatigue, Product dose omission issue,

25060662

US

Nasopharyngitis, Fatigue,

CILTACABTAGENE AUTOLEUCEL,

25060761

CA

Exposure during pregnancy, Infusion related reaction, Injury, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Laryngitis, Live birth, Liver function test increased, Liver injury, Lower limb fracture, Lupus-like syndrome, Lupus vulgaris, Maternal exposure during pregnancy, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema,

ERENUMAB-AOOE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE,

25060949

US

Influenza, Nasopharyngitis, Illness,

ELOSULFASE ALFA, MONTELUKAST SODIUM, MONTELUKAST, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, EPINEPHRINE, ADRENALINUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ALTEPLASE, FAMOTIDINE,

25062343

Nasopharyngitis, Intentional dose omission,

UPADACITINIB,

25062357

Nasopharyngitis, Inappropriate schedule of product administration,

ADALIMUMAB,

25063147

Back pain, Nasopharyngitis,

IXEKIZUMAB,

25055659

US

Nervousness, Malaise, Rash pruritic, Nasopharyngitis, Therapeutic response decreased,

DUPILUMAB, DUPILUMAB,

25055720

US

Discomfort, Cough, Pruritus, Nasopharyngitis, Condition aggravated, Accidental exposure to product, Exposure via skin contact,

DUPILUMAB, DUPILUMAB,

25055810

US

Nasopharyngitis, Product use in unapproved indication,

DUPILUMAB, DUPILUMAB,

25055990

US

Nasopharyngitis, Wheezing, Device use error,

ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL,

25056109

US

Asthma, Nasopharyngitis,

DUPILUMAB,

25054634

US

Nasal congestion, Nasopharyngitis,

DUPILUMAB, DUPILUMAB,

25054635

US

Nasopharyngitis, Aphonia, Cough,

INSULIN GLARGINE AND LIXISENATIDE,

25054761

US

Peripheral swelling, Nasopharyngitis,

TROFINETIDE, ESOMEPRAZOLE MAGNESIUM, LANSOPRAZOLE,

25054923

CA

Asthma, Blindness, Blood cholesterol abnormal, Blood pressure increased, Cataract, Chest pain, Contusion, Dyspnoea, Forced expiratory volume decreased, Infection, Inflammation, Malaise, Nasopharyngitis, Pain, Product dose omission issue, Pulmonary embolism, Seasonal allergy, Swelling, Tension, Vertigo, Weight decreased, Wheezing,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, BUDESONIDE, PREDNISONE,

25055046

CA

Bacterial infection, Blister, Blood pressure systolic increased, COVID-19, Cataract, Cellulitis, Cough, Depression, Dyspnoea, Erythema, Heart rate increased, Influenza like illness, Localised infection, Malaise, Nasopharyngitis, Oedema peripheral, Pruritus, Rhinorrhoea, Secretion discharge, Skin disorder, Type 2 diabetes mellitus, Vaccination site pain, Weight decreased, Product dose omission issue, Off label use, Drug ineffective,

OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, AMLODIPINE, ROFLUMILAST, GLYCOPYRROLATE, MONTELUKAST SODIUM, MONTELUKAST, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE,

25055074

US

Nasopharyngitis,

TREPROSTINIL, TREPROSTINIL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, SPIRONOLACTONE, ERGOCALCIFEROL, VITAMIN E, CREAM, MACITENTAN, HYDROXYCHLOROQUINE SULFATE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, OXYGEN, 0XYGEN, FERROUS SULFATE, TORSEMIDE,